Kantarjian, H. M., Zugmaier, G., Brüggemann, M., Wood, B. L., Horst, H. A., Zeng, Y., & Martinelli, G. (2021). Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. MDPI AG.
Style de citation Chicago (17e éd.)Kantarjian, Hagop M., Gerhard Zugmaier, Monika Brüggemann, Brent L. Wood, Heinz A. Horst, Yi Zeng, et Giovanni Martinelli. Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. MDPI AG, 2021.
Style de citation MLA (8e éd.)Kantarjian, Hagop M., et al. Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. MDPI AG, 2021.